Abstract:Chest radiography (CXR) for the diagnosis of pulmonary complications offers portability and wide accessibility and is inexpensive. CXR is often the first imaging modality for the detection of lung disease and, thus, shapes disease management strategy (1). Despite the significance and obvious advantages, the inconsistent interpretation of CXR and associated reporting delays continue to be a significant burden in various healthcare settings (2–5). Alternatively, recent advances in convolutional neural networks have led to the birth of several stand-alone artificial intelligence (AI) tools to interpret CXR. Several studies have evaluated the impact of AI as an assistant to the workflow of radiologists in the detection and localization of key radiographic findings and in clinical decision making (6, 7). There is an augmented curiosity but a cautious adoption of AI-based diagnostics by radiologists (8). AI algorithms have been developed and deployed for specific CXR diagnostic tasks, such as detection of lung nodules (7), emphysema (9), pneumonia (10), and pneumothorax (11), which have exhibited radiologist-level performance and accuracy. Even though AI applications in CXR diagnosis have been shown to aid radiologists in detection of key radiographic findings, the benefit of AI-assisted CXR diagnosis and interpretation by nonradiologist physicians has not been well examined. Furthermore, it is unclear how deep learning and AI-based applications will integrate into a nonradiologist’s clinical workflow and what impact they will have on their efficiency. In this issue ofAnnalsATS, Lee and colleagues (pp. 660–667) designed a prospective, randomized, multicenter study to evaluate the impact of AI assistance on the detection and localization of lung lesions on CXR by nonradiologist physicians (12). The CXRs were randomized into an intervention group of 162 patients, in which CXR interpretation was aided by AI, and a control group of 161 patients, in which CXR interpretation was performed by nonradiologist physicians without the aid of AI. The accuracy of the AI algorithm was verified by three expert radiologists. In diagnosing the presence of lesions, the area under the curve (AUC) was 0.84 (95% confidence interval [CI], 0.77–0.90) for the intervention group, compared with 0.71 (95% CI, 0.64–0.79) for the control group (P value=0.017). The intervention was associated with significantly higher sensitivity and negative predictive value. In localizing lesions on CXR, the results followed a similar pattern, with an AUC of 0.80 (95% CI, 0.74–0.86) for physicians with AI assistance and 0.67 (95% CI, 0.60–0.75) in the control group (P=0.01). The study also reported between-group comparisons of the diagnostic accuracy when aided by chest computed tomography (CT) findings instead of AI. Interestingly, there was no significant difference between the intervention and the control groups in detecting lung lesions. At regional localization of lesions based on chest CT findings, the intervention group had a significantly higher area under the precisionrecall curve of 0.86, versus 0.69 in the control group (P=0.009). The study also included the effect of AI assistance on physicians’ clinical decisions as a secondary endpoint. There were no significant differences between the intervention group and the control group in the follow-up recommendations of clinical procedures, including chest CT, bronchoscopy, biopsy, and surgery. This is a carefully constructed and much-needed study measuring the impact of AI assistance on nonradiologist physicians from several outpatient clinics. The real clinical benefits of any AI-based diagnostic platform should include higher diagnostic accuracy with improved reporting efficiency, resulting in reduced false-positive and false-negative rates. AI-aided radiologic interpretation of lung lesions provided a significant advantage for physicians in the detection and localization of lung lesions and decreased the false referral rate. The control group without AI assistance had a higher frequency of followup chest CT scans than the intervention group. We should, however, note certain limitations. Although AI helped in imagebased detection and localization, it is critical to note that there was no significant difference between the two groups in terms of follow-up clinical decisions. This may depend on the population selected and frequency of clinical decision making using CXR. The authors missed an opportunity by not evaluating the time saved and improvements to clinical workflows in the AI-assisted physicians group. Although AI results were verified by three expert radiologists, there is less clarity on the

Early experiences of integrating an artificial intelligence-based diagnostic decision support system into radiology settings: a qualitative study

Evolution of radiology staff perspectives during artificial intelligence (AI) implementation for expedited lung cancer triage

Evaluating the performance of artificial intelligence software for lung nodule detection on chest radiographs in a retrospective real-world UK population

Evaluating artificial intelligence's role in lung nodule diagnostics: A survey of radiologists in two pilot tertiary hospitals in China

The Impact of Expectation Management and Model Transparency on Radiologists' Trust and Utilization of AI Recommendations for Lung Nodule Assessment on Computed Tomography: Simulated Use Study

Who Goes First? Influences of Human-AI Workflow on Decision Making in Clinical Imaging

An experimental machine learning study investigating the decision-making process of students and qualified radiographers when interpreting radiographic images

Evaluating artificial intelligence’s role in lung nodule diagnostics: A survey of radiologists in two pilot tertiary hospitals in China

Integration and evaluation of chest X-ray artificial intelligence in clinical practice

Artificial intelligence (AI) implementation within the National Health Service (NHS): the South West London AI Working Group experience

Implementation of Artificial Intelligence–Assisted Chest X-ray Interpretation: It Is About Time

Enhancing Early Lung Cancer Detection on Chest Radiographs with AI-assistance: A Multi-Reader Study

Barriers and facilitators to implementing imaging-based diagnostic artificial intelligence-assisted decision-making software in hospitals in China: a qualitative study using the updated Consolidated Framework for Implementation Research

Stakeholder perspectives towards diagnostic artificial intelligence: a co-produced qualitative evidence synthesis

Impact of artificial intelligence assistance on pulmonary nodule detection and localization in chest CT: a comparative study among radiologists of varying experience levels

Navigating the Spectrum: Assessing the Concordance of ML-Based AI Findings with Radiology in Chest X-Rays in Clinical Settings

From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics

Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies

Artificial Intelligence for Optimizing Cancer Imaging: User Experience Study

Artificial intelligence and radiomics in pulmonary nodule management: current status and future applications

Nonradiology Health Care Professionals Significantly Benefit From AI Assistance in Emergency-Related Chest Radiography Interpretation